UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation

PloS one, 2023-11, Vol.18 (11), p.e0292833-e0292833

2023

Volltextzugriff (PDF)

Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera

Frontiers in immunology, 2023-08, Vol.14, p.1219546-1219546

2023

Volltextzugriff (PDF)

Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses

Viruses, 2022-08, Vol.14 (8), p.1793

2022

Volltextzugriff (PDF)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (6), p.2091865-2091865

2022

Volltextzugriff (PDF)

A Single V672F Substitution in the Spike Protein of Field-Isolated PEDV Promotes Cell⁻Cell Fusion and Replication in VeroE6 Cells

Viruses, 2019-03, Vol.11 (3), p.282

2019

Volltextzugriff (PDF)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques

Frontiers in plant science, 2022-09, Vol.13, p.901978-901978

2022

Volltextzugriff (PDF)

SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages

PeerJ (San Francisco, CA), 2023-03, Vol.11, p.e14918-e14918, Article e14918

2023

Volltextzugriff (PDF)

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations

Frontiers in immunology, 2023-01, Vol.13, p.1080791-1080791

2023

Volltextzugriff (PDF)

A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model

Vaccines (Basel), 2021-08, Vol.9 (8), p.850

2021

Volltextzugriff (PDF)

PEDV ORF3 Independently Regulates IκB Kinase β-Mediated NF-κB and IFN-β Promoter Activities

Pathogens (Basel), 2020-05, Vol.9 (5), p.376

2020

Volltextzugriff (PDF)

Production and Immunogenicity Assessment of LTp50: An Escherichia coli -Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (3), p.302

2024

Volltextzugriff (PDF)

In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion

PloS one, 2016-06, Vol.11 (6), p.e0157287

2016

Volltextzugriff (PDF)

Hsp90 interacts with multiple dengue virus 2 proteins

Scientific reports, 2018-03, Vol.8 (1), p.4308-13, Article 4308

2018

Volltextzugriff (PDF)

Pseudotyped zoonotic thogotoviruses exhibit broad entry range in mammalian cells

Virology (New York, N.Y.), 2024-01, Vol.589, p.109914-109914, Article 109914

2024

Volltextzugriff (PDF)

Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus

Archives of virology, 2018-12, Vol.163 (12), p.3255-3264

2018

Volltextzugriff (PDF)

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial

The Journal of infection, 2022-10, Vol.85 (4), p.436-480

2022

Volltextzugriff (PDF)

Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern

Journal of medical virology, 2022-09, Vol.94 (9), p.4265-4276

2022

Volltextzugriff (PDF)

Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults

The Journal of infectious diseases, 2023-10, Vol.228 (7), p.868-877

2023

Volltextzugriff (PDF)

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

Vaccine, 2023-04, Vol.41 (17), p.2781-2792

2023

Volltextzugriff (PDF)

Production and Immunogenicity Assessment of LTp50: An IEscherichia coli/I-Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (3)

2024

Volltextzugriff (PDF)

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers

Scientific reports, 2023-09, Vol.13 (1), p.15648-15648, Article 15648

2023

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(17)
Covid-19
(12)
Antibodies
(11)
Proteins
(11)
Sars-Cov-2
(11)
Severe Acute Respiratory Syndrome Coronavirus 2
(11)
Coronaviruses
(10)
Covid-19 Vaccines
(10)
Immunogenicity
(10)
Vaccines
(10)
Immunology
(9)
Viruses
(9)
Humans
(8)
Immunoglobulin G
(8)
Animals
(6)
Immune Response
(6)
Multidisciplinary Sciences
(6)
Science & Technology - Other Topics
(6)
Virology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Scientific Reports
(3)
Vaccines
(3)
Frontiers In Immunology
(2)
Pharmaceuticals
(2)
Plos One
(2)
The Journal Of Infectious Diseases
(2)
Vaccine
(2)
Viruses
(2)
Archives Of Virology
(1)
Asian Pacific Journal Of Allergy And Immunology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation

Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera

Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

A Single V672F Substitution in the Spike Protein of Field-Isolated PEDV Promotes Cell⁻Cell Fusion and Replication in VeroE6 Cells

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques

SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations

A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model

PEDV ORF3 Independently Regulates IκB Kinase β-Mediated NF-κB and IFN-β Promoter Activities

Production and Immunogenicity Assessment of LTp50: An Escherichia coli -Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein

In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice

Hsp90 interacts with multiple dengue virus 2 proteins

Pseudotyped zoonotic thogotoviruses exhibit broad entry range in mammalian cells

Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial

Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern

Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5–11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial

Production and Immunogenicity Assessment of LTp50: An IEscherichia coli/I-Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers

Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study

Suchergebnisse filtern